breast cancer patients may be spared chemotherapy thanks to new tests that pinpoint genetic ' markers ' breast cancer patients may be spared chemotherapy thanks to new tests that pinpoint genetic ' markers ' in the tumour and determine its aggressiveness
after surgery , the cancer cells are sent to a lab where they are screened , and women can be told within days whether they have a high or low risk of the disease returning
the majority of women who have breast cancer are routinely given the gruelling drug treatment following removal of the tumour to prevent recurrence
but experts have long - believed that the risk of cancer recurrence for certain women is a lot less than for others , and that for some , chemotherapy may not be necessary
most of the tests are available only privately and cost about Â£ 2,500 , although breast specialists hope they may soon become properly available on the nhs
' becca , a 49 - year - old mother of three aged 11 , six and four , was recovering from being diagnosed and treated for breast cancer last year only to then discover that she had cancer in her other breast
the majority of women who have breast cancer are routinely given the gruelling drug treatment following removal of the tumour to prevent recurrence she said : ' i dreaded chemo more than another mastectomy